The Technical Analyst
Artemis Therapeutics Inc. [ATMS]
Exchange: PNK Industry: Biotechnology
Artemis Therapeutics Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-73.65% $0.498
America/New_York / 25 mai 2023 @ 11:53
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 55.79 mill |
| EPS: | -0.0600 |
| P/E: | -8.30 |
| Earnings Date: | Aug 21, 2023 |
| SharesOutstanding: | 112.03 mill |
| Avg Daily Volume: | 0.0015 mill |
| RATING 2023-05-25 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | ||||||
| Asset | n/a | |||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -8.30 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -8.30 | industry: PE -107.25 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.449 - 0.547 ( +/- 9.84%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-06-30 | Citron Shimon | Sell | 0 | Common Stock |
| 2022-06-30 | Citron Shimon | Buy | 0 | Common Stock |
| 2022-06-30 | Citron Shimon | Sell | 32 772 000 | Series D Preferred Stock |
| 2022-06-30 | Citron Shimon | Buy | 21 848 400 | Series D Preferred Stock |
| 2022-07-26 | Dana David | Buy | 0 |
| INSIDER POWER |
|---|
| -100.00 |
| Last 89 transactions |
| Buy: 13 432 446 | Sell: 33 776 448 |
Forecast:
01:40 - $0.464
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.498 (-73.65% ) |
| Volume | 0.0011 mill |
| Avg. Vol. | 0.0015 mill |
| % of Avg. Vol | 70.86 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ATMS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ATMS
Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.